Bovie Medical entered into a global sales channel partnership agreement with CONMED for its PlazXact™ Ablator, which will be marketed as the UltrAblator Bipolar® series effective in March 2017.
The PlazXact ablator is a sterile, single-use device for the cutting, coagulating and ablation of soft tissue in arthroscopic procedures.
The agreement complements ConMed’s strategy to provide a full range of competitively-priced ablator products that cover a variety of arthroscopic procedures for small and large joints.
Sources: Bovie Medical Corporation and ConMed Corporation; boviemedical.com
Bovie Medical entered into a global sales channel partnership agreement with CONMED for its PlazXact™ Ablator, which will be marketed as the UltrAblator Bipolar® series effective in March 2017.
The PlazXact ablator is a sterile, single-use device for the cutting, coagulating and ablation of soft tissue in arthroscopic procedures.
The...
Bovie Medical entered into a global sales channel partnership agreement with CONMED for its PlazXact™ Ablator, which will be marketed as the UltrAblator Bipolar® series effective in March 2017.
The PlazXact ablator is a sterile, single-use device for the cutting, coagulating and ablation of soft tissue in arthroscopic procedures.
The agreement complements ConMed’s strategy to provide a full range of competitively-priced ablator products that cover a variety of arthroscopic procedures for small and large joints.
Sources: Bovie Medical Corporation and ConMed Corporation; boviemedical.com
You are out of free articles for this month
Subscribe as a Guest for $0 and unlock a total of 5 articles per month.
You are out of five articles for this month
Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.
JV
Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.